[ad_1] Le laboratoire Merck badure 6 mardi 2018 que les patients français qui disposent d’une ordonnance pourraient se procurer l’ancienne formule du Levothyrox tout au long de l’année 2019. Il ne s’agira …
Read More »Levothyrox: the old formula available one more year
[ad_1] The old formula of Levothyrox will be available again in pharmacy in 2019. 50,000 boxes will be made available per month on the French market, and prescribed to patients who have …
Read More »Levothyrox: towards a commercialization of the new formula throughout Europe?
[ad_1] Paris, Friday, July 27, 2018 – With the exception of the introduction in 2015 of a modified composition in Belgium (introduction which had been accompanied by an increase in side effects …
Read More »The new Levothyrox formula launched in 21 European countries in 2019
[ad_1] The Merck laboratory plans to launch the new formula Levothyrox in 21 countries of the European Union from 2019, after a " positive opinion " of European health authorities, he said …
Read More »Levothyrox: the new formula soon in all Europe
[ad_1] The controversy over the new formula of Levothyrox does not slow down the laboratory which plans to market it in 21 European countries. France is the first market to have launched …
Read More »42 patients sue Merck in Levothyrox case
[ad_1] Aille, October 29, 2017 – Illustration of a box of Levothyrox drugs. – Gilles Durand / 20 Minutes They decided to continue the fight. Forty-two "victims" of the new formula of …
Read More »Levothyrox: Merck sued by 42 patients in Toulouse
[ad_1] Toulouse – Forty-two plaintiffs of Levothyrox have sued the Merck laboratory in the Toulouse tribunal de grande instance, demanding compensation, expertise and the maintenance of the marketing of the old formula, …
Read More »Levothyrox New Formula: the Agence du médicament confirms its "good quality"
[ad_1] No, the new formula Levothyrox is neither under-dosed nor contaminated, denies the Agence du Medecine (ANSM), following accusations of the French Association of Thyroid Patients (AFMT). The badociation had indeed carried …
Read More »New Levothyrox: adverse effects remain unexplained
[ad_1] The third pharmacovigilance report on Levothyrox, released Friday by the Agence du médicament, still does not explain the wave of adverse reactions attributed by some patients to the new formula of …
Read More »The Agence du médicament confirms the good quality of the new Levothyrox
[ad_1] The change in formulation of this drug in March 2017 was followed by an unprecedented number of reports of adverse effects, but this has not yet been explained. Is the new …
Read More »